KWALITY PHARMACEUTICALS
|
KWALITY PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity - Authorised | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity - Issued | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity Paid Up | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹214 Cr | ₹190 Cr | ₹171 Cr | ₹51 Cr | ₹36 Cr |
Securities Premium | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Capital Reserves | - | - | - | ₹0.08 Cr | ₹0.08 Cr |
Profit & Loss Account Balance | ₹205 Cr | ₹181 Cr | ₹161 Cr | ₹41 Cr | ₹26 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.76 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr |
Reserve excluding Revaluation Reserve | ₹213 Cr | ₹189 Cr | ₹170 Cr | ₹50 Cr | ₹35 Cr |
Revaluation reserve | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr |
Shareholder's Funds | ₹224 Cr | ₹201 Cr | ₹181 Cr | ₹61 Cr | ₹46 Cr |
Minority Interest | ₹-1.63 Cr | ₹-1.45 Cr | ₹-1.36 Cr | ₹-1.30 Cr | ₹-1.04 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹20 Cr | ₹27 Cr | ₹20 Cr | ₹16 Cr | ₹8.18 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹32 Cr | ₹39 Cr | ₹30 Cr | ₹16 Cr | ₹8.08 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-13 Cr | ₹-12 Cr | ₹-11 Cr | ₹0.07 Cr | ₹0.10 Cr |
Unsecured Loans | - | ₹0.12 Cr | ₹0.70 Cr | ₹2.00 Cr | ₹2.00 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | ₹0.12 Cr | ₹0.70 Cr | ₹2.00 Cr | ₹2.00 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.03 Cr | ₹0.41 Cr | ₹0.28 Cr | ₹-0.04 Cr | ₹-0.20 Cr |
Deferred Tax Assets | ₹0.44 Cr | - | ₹0.04 Cr | ₹0.20 Cr | ₹0.32 Cr |
Deferred Tax Liability | ₹0.41 Cr | ₹0.41 Cr | ₹0.31 Cr | ₹0.16 Cr | ₹0.12 Cr |
Other Long Term Liabilities | - | - | - | ₹9.18 Cr | ₹9.18 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.22 Cr | ₹0.90 Cr | ₹0.75 Cr | ₹0.68 Cr | ₹0.62 Cr |
Total Non-Current Liabilities | ₹20 Cr | ₹29 Cr | ₹21 Cr | ₹28 Cr | ₹20 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹44 Cr | ₹35 Cr | ₹35 Cr | ₹26 Cr | ₹23 Cr |
Sundry Creditors | ₹44 Cr | ₹35 Cr | ₹35 Cr | ₹26 Cr | ₹23 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹35 Cr | ₹33 Cr | ₹41 Cr | ₹30 Cr | ₹21 Cr |
Bank Overdraft / Short term credit | - | - | - | ₹0.47 Cr | ₹1.04 Cr |
Advances received from customers | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹21 Cr | ₹14 Cr |
Interest Accrued But Not Due | ₹0.19 Cr | ₹0.23 Cr | ₹0.14 Cr | ₹0.10 Cr | ₹0.05 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹16 Cr | ₹15 Cr | ₹22 Cr | ₹8.32 Cr | ₹5.19 Cr |
Short Term Borrowings | ₹66 Cr | ₹51 Cr | ₹23 Cr | ₹16 Cr | ₹21 Cr |
Secured ST Loans repayable on Demands | ₹66 Cr | ₹51 Cr | ₹23 Cr | ₹16 Cr | ₹21 Cr |
Working Capital Loans- Sec | ₹66 Cr | ₹51 Cr | ₹23 Cr | ₹16 Cr | ₹21 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-66 Cr | ₹-51 Cr | ₹-23 Cr | ₹-16 Cr | ₹-21 Cr |
Short Term Provisions | ₹6.61 Cr | ₹6.48 Cr | ₹41 Cr | ₹5.80 Cr | ₹3.00 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹6.52 Cr | ₹6.48 Cr | ₹41 Cr | ₹5.80 Cr | ₹3.00 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.08 Cr | - | - | - | - |
Total Current Liabilities | ₹152 Cr | ₹126 Cr | ₹139 Cr | ₹78 Cr | ₹68 Cr |
Total Liabilities | ₹394 Cr | ₹354 Cr | ₹341 Cr | ₹166 Cr | ₹132 Cr |
ASSETS | |||||
Gross Block | ₹207 Cr | ₹170 Cr | ₹128 Cr | ₹82 Cr | ₹63 Cr |
Less: Accumulated Depreciation | ₹69 Cr | ₹50 Cr | ₹36 Cr | ₹26 Cr | ₹20 Cr |
Less: Impairment of Assets | ₹-1.63 Cr | - | - | - | - |
Net Block | ₹139 Cr | ₹120 Cr | ₹92 Cr | ₹57 Cr | ₹43 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | ₹14 Cr | ₹12 Cr | ₹2.89 Cr | - |
Non Current Investments | - | - | - | ₹0.73 Cr | ₹0.65 Cr |
Long Term Investment | - | - | - | ₹0.73 Cr | ₹0.65 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | ₹0.73 Cr | ₹0.65 Cr |
Long Term Loans & Advances | ₹12 Cr | ₹11 Cr | ₹8.11 Cr | ₹0.17 Cr | ₹0.12 Cr |
Other Non Current Assets | - | ₹0.93 Cr | ₹0.78 Cr | - | - |
Total Non-Current Assets | ₹151 Cr | ₹146 Cr | ₹113 Cr | ₹60 Cr | ₹43 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | ₹4.44 Cr | ₹3.34 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | ₹4.44 Cr | ₹3.34 Cr |
Inventories | ₹78 Cr | ₹86 Cr | ₹53 Cr | ₹17 Cr | ₹22 Cr |
Raw Materials | ₹49 Cr | ₹57 Cr | ₹31 Cr | ₹7.88 Cr | ₹11 Cr |
Work-in Progress | ₹2.02 Cr | - | - | - | - |
Finished Goods | ₹11 Cr | ₹12 Cr | ₹8.36 Cr | ₹5.85 Cr | ₹5.94 Cr |
Packing Materials | ₹16 Cr | ₹25 Cr | ₹14 Cr | ₹3.64 Cr | ₹5.39 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹0.25 Cr | ₹-7.05 Cr | - | - | - |
Sundry Debtors | ₹114 Cr | ₹72 Cr | ₹69 Cr | ₹36 Cr | ₹30 Cr |
Debtors more than Six months | ₹32 Cr | ₹29 Cr | ₹17 Cr | ₹5.93 Cr | ₹6.86 Cr |
Debtors Others | ₹82 Cr | ₹43 Cr | ₹52 Cr | ₹30 Cr | ₹23 Cr |
Cash and Bank | ₹5.94 Cr | ₹7.36 Cr | ₹13 Cr | ₹5.81 Cr | ₹1.54 Cr |
Cash in hand | ₹0.16 Cr | ₹0.37 Cr | ₹0.64 Cr | ₹0.26 Cr | ₹0.19 Cr |
Balances at Bank | ₹5.79 Cr | ₹6.99 Cr | ₹12 Cr | ₹5.55 Cr | ₹1.35 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹7.03 Cr | - | - | ₹0.09 Cr | ₹0.12 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | ₹0.09 Cr | ₹0.08 Cr |
Other current_assets | ₹7.03 Cr | - | - | - | ₹0.04 Cr |
Short Term Loans and Advances | ₹37 Cr | ₹42 Cr | ₹92 Cr | ₹42 Cr | ₹31 Cr |
Advances recoverable in cash or in kind | ₹13 Cr | ₹10 Cr | ₹25 Cr | ₹13 Cr | ₹6.51 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹24 Cr | ₹31 Cr | ₹67 Cr | ₹29 Cr | ₹25 Cr |
Total Current Assets | ₹243 Cr | ₹207 Cr | ₹228 Cr | ₹106 Cr | ₹89 Cr |
Net Current Assets (Including Current Investments) | ₹91 Cr | ₹81 Cr | ₹88 Cr | ₹28 Cr | ₹21 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹394 Cr | ₹354 Cr | ₹341 Cr | ₹166 Cr | ₹132 Cr |
Contingent Liabilities | ₹0.35 Cr | ₹0.51 Cr | ₹0.05 Cr | ₹0.59 Cr | ₹1.27 Cr |
Total Debt | ₹98 Cr | ₹90 Cr | ₹54 Cr | ₹41 Cr | ₹35 Cr |
Book Value | 215.31 | 192.48 | 173.81 | 58.16 | 43.57 |
Adjusted Book Value | 215.31 | 192.48 | 173.81 | 58.16 | 43.57 |
Compare Balance Sheet of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹864.2 Cr | -6.4% | -4.1% | 78.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -6.4% |
-4.1% |
78.6% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses